Cargando…
Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer
[Image: see text] The epidermal growth factor receptor (EGFR) is a validated therapeutic target for triple-negative breast cancer (TNBC). In the present study, we synthesize novel adamantanyl-based thiadiazolyl pyrazoles by introducing the adamantane ring to thiazolopyrazoline. On the basis of loss...
Autores principales: | Sebastian, Anusha, Pandey, Vijay, Mohan, Chakrabhavi Dhananjaya, Chia, Yi Ting, Rangappa, Shobith, Mathai, Jessin, Baburajeev, C. P., Paricharak, Shardul, Mervin, Lewis H., Bulusu, Krishna C., Fuchs, Julian E., Bender, Andreas, Yamada, Shuhei, Basappa, Lobie, Peter E., Rangappa, Kanchugarakoppal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044684/ https://www.ncbi.nlm.nih.gov/pubmed/30023509 http://dx.doi.org/10.1021/acsomega.6b00251 |
Ejemplares similares
-
A Nano-MgO and Ionic Liquid-Catalyzed ‘Green’ Synthesis Protocol for the Development of Adamantyl-Imidazolo-Thiadiazoles as Anti-Tuberculosis Agents Targeting Sterol 14α-Demethylase (CYP51)
por: Anusha, Sebastian, et al.
Publicado: (2015) -
Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity
por: Baburajeev, C. P., et al.
Publicado: (2017) -
A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A(2)
por: Anilkumar, Nirvanappa C., et al.
Publicado: (2015) -
Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway
por: Mohan, Chakrabhavi Dhananjaya, et al.
Publicado: (2016) -
New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis
por: Barash, Uri, et al.
Publicado: (2021)